Pharmacological Ascorbate Induces ‘BRCAness’ and Enhances the Effects of Poly(ADP‑Ribose) Polymerase Inhibitors Against BRCA1/2 Wild‑type Ovarian Cancer
Oncology Letters - Greece
doi 10.3892/ol.2020.11364
Full Text
Open PDFAbstract
Available in full text
Date
January 31, 2020
Authors
Publisher
Spandidos Publications